youtube_live
Q3 2026 earnings • released • EPS beat +3,85% • Revenue beat +35,39%
See resultschevron_right
SDGR:NASDAQ
Schrodinger Inc
29,82 $
arrow_upward
+3,65%(+1,05) 1D
30,30 $
arrow_upward
+1,61% (+0,48)bedtimeAfter hours
Closed: 6 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDGR...
Open
29,39 $
High
30,88 $
Low
28,53 $
Mkt. cap
2,23 մլրդ
Avg. vol.
2,32 մլն
Volume
1,43 մլն
52-wk high
33,78 $
52-wk low
10,94 $
EPS
-0,79 $
Beta
1,69
Shares outstanding
65,91 մլն
No. of employees
850
Open
29,39 $
High
30,88 $
Low
28,53 $
Mkt. cap
2,23 մլրդ
Avg. vol.
2,32 մլն
Volume
1,43 մլն
52-wk high
33,78 $
52-wk low
10,94 $
EPS
-0,79 $
Beta
1,69
Shares outstanding
65,91 մլն
No. of employees
850
News stories
From web sources and news partners
Yahoo Finance
·
1 օր առաջ
Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
Yahoo Finance
·
3 օր առաջ
Schrödinger, Inc. Q3 2026 Earnings Call Summary
GuruFocus
·
3 օր առաջ
Schrödinger (SDGR) Reports Strong Q3 Growth, Raises 2026 ACV Gui
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc